[fam-] trastuzumab deruxtecan, antitumor activity is dependent on HER2 expression level rather than on HER2 amplification.

Takegawa N, Tsurutani J, Kawakami H, Yonesaka K, Kato R, Haratani K, Hayashi H, Takeda M, Nonagase Y, Maenishi O, Nakagawa K
Int J Cancer. 2019 May 14. doi: 10.1002/ijc.32408. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.